The global clinical decision support system (CDSS) market is likely to be valued at USD 3,210 million by 2027, at a CAGR of 18.4% from 2021–2027. Increasing incidence of medication errors along with growing investments in order to improve the quality of care is projected to propel the market growth. Also, several government initiatives to promote the adoption of automated healthcare solutions are likely to drive the market for clinical decision support system (CDSS) over the forecast period. However, lack of skilled personnel for technology use as well as high implementation costs may hinder the market growth to some extent.
Clinical decision support system (CDSS) is a tool that is used to improve operational efficiency in the healthcare sector and assist clinicians by providing expertise from diagnosis to monitoring and follow-up. These systems integrate patient data with medical knowledge and aim at providing appropriate suggestions based on that. CDSS are often incorporated within electronic health records (EHR), and integrated with other computer-based functions that provide patient-care summary reports, and feedback on quality indicators.
The report provides detailed market outlook, and forecast the “Global Clinical Decision Support System (CDSS)” market based on component, model, delivery model, product, application, end-use and region.
Segment overview
On the basis of component, the software segment held the largest share of the global market in 2020, and the trend is expected to continue over the forecast period. CDSS software is developed to assist the clinical decision making tasks by ensuring that all medical information is accurate. There are various types of software tools used in CDSS, such as software for storage and maintenance of clinical data, statistical investigation and reporting software.
On the basis of model, CDSS are of two main types, knowledge-based CDSS and non-knowledge based CDSS. The knowledge-based CDSS uses a knowledge base, and applies rules to patient data by using an inference engine and displays results to the end users. The non-knowledge based CDSS systems rely on machine learning to analyze clinical data. The knowledge-based segment accounted for the largest share of the global market in 2019, and is expected to grow at a significant CAGR over the coming years.
On the basis of region, North America held the largest share of the global CDSS market and is projected to continue its dominance over the forecast period, owing to favorable government policies coupled with technological advancements. The massive unexplored CDSS market across the globe has created abundant opportunities for the major players to exploit its full potential. Although, there has been significant development in the developed economies of Europe and the U.S., the CDSS market is still at its nascent form, especially in the emerging economies of Asia-Pacific, CSA, and Africa. A high growth in the number of end users including hospitals, and pharmacy has been witnessed in the developing countries of these regions, which provides immense growth opportunities for the CDSS market.
Key players operating in the market include EPIC Systems Corporation; International Business Machine (IBM) Corporation; CERNER CORPORATION; Mckesson Corporation; Allscripts Healthcare Solutions, Inc; F. Hoffmann-La Roche Ltd; and Siemens Healthcare; among others.
| Research Attribute | Coverage |
|---|---|
| Years Considered | 2017-2027 |
| Historical Years | 2017, 2018, 2019 |
| Base Year | 2020 |
| Forecast Period | 2021-2027 |
| Units Considered | USD Million |
| Segmentation By Component |
|
| Segmentation by Model |
|
| Segmentation by Delivery Model |
|
| Segmentation by Product |
|
| Segmentation by Application |
|
| Segmentation by End-Use |
|
| Regions Covered |
|
| Key Company Profiles | EPIC Systems Corporation, International Business Machine (IBM) Corporation, CERNER CORPORATION, Mckesson Corporation, Allscripts Healthcare Solutions, Inc, F. Hoffmann-La Roche Ltd, & Siemens Healthcare, among others. |
CHAPTER 1. Market Scope and Methodology
1.1. Market Definition
1.2. Market Segmentation
1.2.1. Market Breakdown, By Component
1.2.2. Market Breakdown, By Model
1.2.3. Market Breakdown, By Product
1.2.4. Market Breakdown, By Delivery Mode
1.2.5. Market Breakdown, By Application
1.2.6. Market Breakdown, By Region
1.3. Research Methodology
1.4. Executive Summary
CHAPTER 2. Market Outlook
2.1. Introduction
2.2. Landscape
2.2.1. Market Share
2.2.2. Opportunities
2.2.2.1. Huge market potential in the emerging economies
2.2.3. Trends
2.2.3.1. Expanding applications of clinical decision support system in variety of clinical activities
2.2.4. Growth Drivers
2.2.4.1. Increasing support from governments across the globe
2.2.4.2. Growing investment by companies in healthcare IT
2.2.4.3. Growing demand for technological advancements in healthcare sector
2.2.5. Impact Analysis of Drivers on Future Forecast of the Market
2.2.6. Restraints of the Market
2.2.6.1. Privacy and security concerns regarding patient information
2.2.6.2. Complexity and Interoperability issues associated with clinical decision support systems
2.2.7. Impact Analysis of Restraints on Future Forecast of the Market
CHAPTER 3. Market Entry Strategy
3.1. Regional Regulatory Affairs
3.2. Competitive Analysis
3.3. Investment Analysis
3.4. Recommendations
CHAPTER 4. Global Clinical Decision Support System Market Size and Forecast (2013 - 2023)
4.1. Global Clinical Decision Support System Market, By Component
4.1.1. Software
4.1.2. Hardware
4.1.3. Services
4.2. Global Clinical Decision Support System Market, By Model
4.2.1. Knowledge-Based Clinical Decision Support Systems
4.2.2. Non-Knowledge-Based Clinical Decision Support Systems
4.3. Global Clinical Decision Support System Market, By Product
4.3.1. Standalone Clinical Decision Support Systems
4.3.2. Integrated Clinical Decision Support Systems
4.3.3. Standard-Based Clinical Decision Support System
4.3.4. Service Model Based Clinical Decision Support System
4.4. Global Clinical Decision Support System Market, By Delivery Mode
4.4.1. Web-Based Clinical Decision Support System
4.4.2. On Premise Clinical Decision Support System
4.4.3. Cloud Based Clinical Decision Support System
4.5. Global Clinical Decision Support System Market, By Application
4.5.1. Drug-Drug Interactions
4.5.2. Clinical Guidelines
4.5.3. Drug Allergy Alerts
4.5.4. Clinical Reminders
4.5.5. Drug Dosing Support
4.5.6. Others
4.6. Global Clinical Decision Support System Market, By Region
4.6.1. North America
4.6.2. Europe
4.6.3. Asia-Pacific
4.6.4. South America
4.6.5. Middle East & Africa(MEA)
CHAPTER 5. Global Clinical Decision Support System Market, By Geography
5.1. North America Clinical Decision Support System Market
5.1.1. North America Clinical Decision Support System Market, By Component
5.1.2. North America Clinical Decision Support System Market, By Model
5.1.3. North America Clinical Decision Support System Market, By Product
5.1.4. North America Clinical Decision Support System Market, By Delivery Mode
5.1.5. North America Clinical Decision Support System Market, By Application
5.1.6. North America Clinical Decision Support System Market, By Country
5.1.6.1. The U.S.
5.1.6.2. Canada
5.1.6.3. Rest of North America
5.2. Europe Clinical Decision Support System Market
5.2.1. Europe Clinical Decision Support System Market, By Component
5.2.2. Europe Clinical Decision Support System Market, By Model
5.2.3. Europe Clinical Decision Support System Market, By Product
5.2.4. Europe Clinical Decision Support System Market, By Delivery Mode
5.2.5 Europe Clinical Decision Support System Market, By Application
5.2.5. Europe Clinical Decision Support System Market, By Country
5.2.5.1. Germany
5.2.5.2. France
5.2.5.3. The U.K.
5.2.5.4. Italy
5.2.5.5. Spain
5.2.5.6. Russia
5.2.5.7. Rest of Europe
5.3. Asia-Pacific Clinical Decision Support System Market
5.3.1. Asia-Pacific Clinical Decision Support System Market, By Component
5.3.2. Asia-Pacific Clinical Decision Support System Market, By Model
5.3.3. Asia-Pacific Clinical Decision Support System Market, By Product
5.3.4. Asia-Pacific Clinical Decision Support System Market, By Delivery Mode
5.3.5. Asia-Pacific Clinical Decision Support System Market, By Application
5.3.3. Asia-Pacific Clinical Decision Support System Market, By Country
5.3.5.1. China
5.3.5.2. Japan
5.3.5.3. India
5.3.5.4. Australia
5.3.5.5. Rest of Asia-Pacific
5.4. South America Clinical Decision Support System Market
5.4.1. South America Clinical Decision Support System Market, By Component
5.4.2. South America Clinical Decision Support System Market, By Model
5.4.3. South America Clinical Decision Support System Market, By Product
5.4.4. South America Clinical Decision Support System Market, By Delivery Mode
5.4.5. South America Clinical Decision Support System Market, By Application
5.4.6. South America Clinical Decision Support System Market, By Country
5.4.6.1. Brazil
5.4.6.2. Rest of South America
5.5. Middle East & Africa (MEA) Clinical Decision Support System Market
5.5.1. Middle East & Africa (MEA) Clinical Decision Support System Market, By Component
5.5.2. Middle East & Africa (MEA) Clinical Decision Support System Market, By Model
5.5.3. Middle East & Africa (MEA) Clinical Decision Support System Market, By Product
5.5.4. Middle East & Africa (MEA) Clinical Decision Support System Market, By Delivery Mode
5.5.5. Middle East & Africa (MEA) Clinical Decision Support System Market, By Application
CHAPTER 6. COMPETITIVE ANALYSIS
6.1. Porters Five Forces Analysis
6.1.1. Bargaining Power of Buyers
6.1.2. Bargaining Power of Suppliers
6.1.3. Threat of New Entrants
6.1.4. Intensity of Rivalry
6.1.5. Threat of Substitutes
CHAPTER 7. Key Players and Strategic Developments
7.1. Cerner Corporation.
7.1.1. Business Overview
7.1.2. Product and Service Offering
7.1.3. Financial Overview
7.1.4. Strategic Developments
7.2. EPIC Systems Corporation
7.2.1. Business Overview
7.2.2. Product and Service Offering
7.2.3. Financial Overview
7.2.4. Strategic Developments
7.3. Allscripts Healthcare Solutions, Inc
7.3.1. Business Overview
7.3.2. Product and Service Offering
7.3.3. Financial Overview
7.3.4. Strategic Developments
7.4. IBM Corporation
7.4.1. Business Overview
7.4.2. Product and Service Offering
7.4.3. Financial Overview
7.4.4. Strategic Developments
7.5. Philips Healthcare
7.5.1. Business Overview
7.5.2. Product and Service Offering
7.5.3. Financial Overview
7.5.4. Strategic Developments
7.6. Mckesson Corporation
7.6.1. Business Overview
7.6.2. Product and Service Offering
7.6.3. Financial Overview
7.6.4. Strategic Developments
7.7. Meditech
7.7.1. Business Overview
7.7.2. Product and Service Offering
7.7.3. Financial Overview
7.7.4. Strategic Developments
7.8. Wolters Kluwer Health
7.8.1. Business Overview
7.8.2. Product and Service Offering
7.8.3. Financial Overview
7.8.4. Strategic Developments
CHAPTER 8. RESEARCH APPROACH
8.1. Initial Data Search
8.2. Secondary Research
8.3. Primary Research
8.4. Scope and Assumptions
